These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging. Fujimoto T; Nakano T; Takano T; Hokazono Y; Asakura T; Tsuji T Acta Psychiatr Scand; 1992 Dec; 86(6):455-62. PubMed ID: 1471539 [TBL] [Abstract][Full Text] [Related]
9. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Fukuzako H; Takeuchi K; Hokazono Y; Fukuzako T; Yamada K; Hashiguchi T; Obo Y; Ueyama K; Takigawa M; Fujimoto T Psychiatry Res; 1995 Nov; 61(4):193-200. PubMed ID: 8748464 [TBL] [Abstract][Full Text] [Related]
10. High-energy phosphate metabolism in the frontal lobes of patients with panic disorder detected by phase-encoded 31P-MRS. Shioiri T; Kato T; Murashita J; Hamakawa H; Inubushi T; Takahashi S Biol Psychiatry; 1996 Oct; 40(8):785-93. PubMed ID: 8894072 [TBL] [Abstract][Full Text] [Related]
11. Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy. O'Callaghan E; Redmond O; Ennis R; Stack J; Kinsella A; Ennis JT; Larkin C; Waddington JL Biol Psychiatry; 1991 Jun; 29(11):1149-52. PubMed ID: 1873375 [No Abstract] [Full Text] [Related]
12. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099 [TBL] [Abstract][Full Text] [Related]
13. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598 [TBL] [Abstract][Full Text] [Related]
14. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. Fukuzako H World J Biol Psychiatry; 2001 Apr; 2(2):70-82. PubMed ID: 12587188 [TBL] [Abstract][Full Text] [Related]
15. Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms. Fukuzako H; Fukuzako T; Takeuchi K; Ohbo Y; Ueyama K; Takigawa M; Fujimoto T Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):629-40. PubMed ID: 8843487 [TBL] [Abstract][Full Text] [Related]
16. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Kato T; Shioiri T; Murashita J; Hamakawa H; Takahashi Y; Inubushi T; Takahashi S Psychol Med; 1995 May; 25(3):557-66. PubMed ID: 7480436 [TBL] [Abstract][Full Text] [Related]
18. High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: a 31phosphorus magnetic resonance spectroscopic and neuropsychological investigation. Volz HP; Hübner G; Rzanny R; Rössger G; Preussler B; Eichhorn M; Kreitschmann-Andermahr I; Kaiser WA; Sauer H Schizophr Res; 1998 May; 31(1):37-47. PubMed ID: 9633835 [TBL] [Abstract][Full Text] [Related]
19. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Shioiri T; Kato T; Inubushi T; Murashita J; Takahashi S Psychiatry Res; 1994 Dec; 55(4):223-35. PubMed ID: 7701036 [TBL] [Abstract][Full Text] [Related]